Clinical trial NCT03986645: Clinical Evaluation of 4D Flow Cardiac MRI Sequences
Official title: Clinical Evaluation of 4D Flow Cardiac MRI Sequences - A Prospective Exploratory Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Indication, Unlabeled
Keywords: 4DFlow
Lead sponsor: University Children's Hospital, Zurich
Sponsor class: OTHER
First posted: 2019-06-14
Enrollment: 8
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: Prospective, exploratory, non-randomized, interventional study without control group.
Primary purpose: BASIC_SCIENCE

Brief summary: Assess the accuracy of 4D flow cardiac MRI to measure blood flow and velocity, delineate 3D cardiac anatomy and visualize flow dynamics using two (2) different pulse sequences.

Detailed description: Advances in pediatric (cardiac) surgery, interventional techniques and medical care have improved survival for children born with congenital heart disease. Assessment of blood flow and pressures within the heart plays an integral role in the management of patients with congenital or acquired structural heart disease aiding with diagnoses, surveillance for complications, in relation to surgical or catheter procedures, and for therapeutic decision making. Current gold standard, direct intracardiac measurement of flow and pressures is an invasive procedure, while non-invasive echography-Doppler is limited by poor acoustic windows and operator dependency.

Therefore, cardiac MRI (cMRI) has been recommended as an important alternative in imaging of pediatric heart disease. Current clinical standard for MR flow imaging is 2-dimensional providing flow in a single cross-sectional plane. Current clinical CMR protocols in pediatric congenital heart disease are time consuming, depend on technician's experience and require direct supervision by an experienced cardiovascular imaging specialist. 4D Flow is a new approach for cMRI that might overcome these disadvantages. It allows scanning of the entire chest in approximately 7 minutes (depending on field of view, heart rate and resolution). The images can be off-line reconstructed in any plane, avoiding the need to precisely define crosssectional planes during acquisition for each vessel. Owing to time resolved visualizations of intracardiac flow dynamics occult jets or dynamic jets might be more likely to be detected. Potential disadvantages, rsp. potential advantages to be confirmed include lower temporal resolution of 4D sequences than current 2D sequences, unknown consequences of gradient artefacts induced by new velocity encoding schemes and diagnostic plausibility of disease related image features .

Eligibility criteria: Inclusion Criteria Patients:

* Clinical referral for cMRI in the absence of any contraindication to cMRI
* Flow measurements are part of the clinical cMRI protocol
* Signed informed consent of participants and/or legal representatives according to current ethical rules and regulations for children and adults
* For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI

Exclusion Criteria Patients:

* Any contraindication for undergoing a cMRI examination or for receiving gadolinium contrast media (renal failure, allergy) per internal institutional policy of University Children's Hospital Zurich
* Any intrathoracic device causing imaging artifacts
* Medical condition at time of examination that would make additional study-related MR scans an unjustified burden or risk.
* Inability or unwillingness to provide informed consent.

Inclusion Criteria Healthy Controls:

* Absence of any contraindication to cMRI
* Signed informed consent of participants according to current ethical rules and regulations
* For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI.

Exclusion Criteria Healthy Controls:

- Any contraindication for undergoing a cMRI examination per internal institutional policy of University Children's Hospital Zurich

Primary outcomes:
measure: Feasibility of data processing
timeFrame: Within 72 hours after completion of exam
Secondary outcomes:
measure: Image quality
timeFrame: Within 72 hours after completion of exam
measure: Comparability
timeFrame: Within 72 hours after completion of exam
measure: Clinical value
timeFrame: Within 72 hours after completion of exam
Other outcomes:
Locations:
Study officials:
affiliation: UChilldrenZurich
name: Emanuela Valsangiacomo, Prof. MD
role: PRINCIPAL_INVESTIGATOR
References: